{"transactions":[{"id":697732,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-04T21:10:22.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-025725","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000143774926025725/rdgdoc.xml","form_type":"4"}},{"id":939533,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-14T23:07:31.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":7757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in one annual installment beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in one annual installment beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":302928,"derivative":{"underlying":"Common Stock","underlying_shares":7757},"source":{"system":"sec-edgar","filing":"0001437749-26-001296","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000143774926001296/rdgdoc.xml","form_type":"4"}},{"id":939532,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-14T23:07:31.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":12196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 12, 2027."}],"balance_after":295171,"derivative":{"exercise_price":15.47,"expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":12196},"source":{"system":"sec-edgar","filing":"0001437749-26-001296","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000143774926001296/rdgdoc.xml","form_type":"4"}},{"id":968042,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Rights","published_at":"2025-12-16T14:28:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":164000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026."}],"balance_after":164000,"derivative":{"exercise_price":4.06,"exercise_date":"2026-03-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":164000},"source":{"system":"sec-edgar","filing":"0001213900-25-121967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390025121967/ownership.xml","form_type":"4"}},{"id":1046531,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-09-08T21:45:40.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are fully vested and exercisable."}],"balance_after":62500,"derivative":{"exercise_price":1.33,"expiration_date":"2035-08-19","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001641172-25-026891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000164117225026891/ownership.xml","form_type":"4"}},{"id":1099535,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-30T23:28:32.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 16 equal quarterly installments commencing on September 26, 2025."}],"balance_after":100000,"derivative":{"exercise_price":0.67,"exercise_date":"2025-09-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-25-059867","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390025059867/ownership.xml","form_type":"4"}},{"id":1311462,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-01-06T21:21:11.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest equally on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 3, 2026."}],"balance_after":25000,"derivative":{"exercise_price":13,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-000464","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000143774925000464/rdgdoc.xml","form_type":"4"}},{"id":1382518,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-23T20:27:07.000Z","date":"2024-10-22","kind":"gift","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-24-089971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390024089971/ownership.xml","form_type":"4"}},{"id":1410108,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T21:47:00.000Z","date":"2024-09-09","kind":"purchase","planned":false,"acquired":true,"shares":13000,"price":2.56,"value":33280.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001213900-24-077794","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390024077794/ownership.xml","form_type":"4"}},{"id":1499420,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T01:23:44.000Z","date":"2024-05-24","kind":"other","planned":false,"acquired":false,"shares":20976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer."}],"balance_after":31522,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":20976},"source":{"system":"sec-edgar","filing":"0001213900-24-047632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390024047632/ownership.xml","form_type":"4"}},{"id":1499419,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T01:23:44.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":20976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the \"December Award\"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the \"Additional Award Shares\") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the \"Plan\"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares."}],"balance_after":52498,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":20976},"source":{"system":"sec-edgar","filing":"0001213900-24-047632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390024047632/ownership.xml","form_type":"4"}},{"id":1577068,"issuer":{"id":93047,"kind":"organization","name":"PaxMedica, Inc.","symbol":"PXMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-14T20:45:35.000Z","date":"2024-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":992,"price":0.69,"value":684.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units."}],"balance_after":2386,"source":{"system":"sec-edgar","filing":"0001104659-24-034545","document":"tm248854-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465924034545/tm248854-1_4seq1.xml","form_type":"4"}},{"id":1641438,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-15T21:18:19.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 13, 2025."}],"balance_after":164555,"derivative":{"exercise_price":4.42,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-24-004363","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000143774924004363/rdgdoc.xml","form_type":"4"}},{"id":1665407,"issuer":{"id":93047,"kind":"organization","name":"PaxMedica, Inc.","symbol":"PXMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T22:17:35.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":97,"price":0.76,"value":73.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units."}],"balance_after":3378,"source":{"system":"sec-edgar","filing":"0001104659-24-008885","document":"tm244774-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465924008885/tm244774-2_4seq1.xml","form_type":"4"}},{"id":1688620,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T22:14:27.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":19633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2024, the Reporting Person was granted 19,633 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning April 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":19937,"source":{"system":"sec-edgar","filing":"0001104659-24-001440","document":"tm242126-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465924001440/tm242126-2_4seq1.xml","form_type":"4"}},{"id":1705384,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-19T22:26:46.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":31522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 15, 2024."}],"balance_after":31522,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":31522},"source":{"system":"sec-edgar","filing":"0001213900-23-097024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390023097024/ownership.xml","form_type":"4"}},{"id":1765703,"issuer":{"id":93047,"kind":"organization","name":"PaxMedica, Inc.","symbol":"PXMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T21:18:20.000Z","date":"2023-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6536,"price":0.2861,"value":1869.9496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units."}],"balance_after":59047,"source":{"system":"sec-edgar","filing":"0001062993-23-019006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000106299323019006/form4.xml","form_type":"4"}},{"id":1779273,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T21:44:21.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":10,"price":0.43,"value":4.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs."}],"balance_after":6098,"source":{"system":"sec-edgar","filing":"0001104659-23-101684","document":"tm2326348-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465923101684/tm2326348-1_4seq1.xml","form_type":"4"}},{"id":1789694,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T00:08:53.000Z","date":"2023-08-31","kind":"sale","planned":false,"acquired":false,"shares":6053,"price":0.3,"value":1815.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3001 to $0.3013. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":6108,"source":{"system":"sec-edgar","filing":"0001104659-23-098422","document":"tm2325486-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465923098422/tm2325486-1_4seq1.xml","form_type":"4"}},{"id":1848400,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-06-21T23:58:43.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares vest on the monthly anniversary of May 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct."}],"balance_after":500000,"derivative":{"exercise_price":0.35,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-23-022059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223022059/ownership.xml","form_type":"4"}},{"id":1875233,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T21:05:44.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":92958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the \"Plan\"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":150000,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":92958},"source":{"system":"sec-edgar","filing":"0001213900-23-044079","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390023044079/ownership.xml","form_type":"4"}},{"id":1919778,"issuer":{"id":93047,"kind":"organization","name":"PaxMedica, Inc.","symbol":"PXMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T23:10:38.000Z","date":"2023-04-13","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 14,000 restricted stock units (\"RSUs\"). The RSUs are subject to time-based vesting with one-third of the RSUs vesting on February 1, 2024, followed by 8.3325% of the remaining RSUs vesting on a quarterly basis thereafter, subject to the reporting person's continuous service with the Company as of such vesting dates."}],"balance_after":65583,"source":{"system":"sec-edgar","filing":"0001104659-23-045771","document":"tm2312952-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465923045771/tm2312952-1_4seq1.xml","form_type":"4"}},{"id":1975150,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-03T21:10:26.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest on a quarterly basis over 12 months form the date of grant until fully vested and exercisable on February 20, 2024."}],"balance_after":134555,"derivative":{"exercise_price":3.47,"expiration_date":"2033-02-19","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-006675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000149315223006675/ownership.xml","form_type":"4"}},{"id":2036699,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T22:00:31.000Z","date":"2021-12-03","kind":"gift","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The La Jolla Lenox Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 3, 2021, the Reporting Person transferred 10,000 shares of the Issuer's common stock to a family trust of which the Trustee is someone other than the Reporting Person. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that The Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-23-007436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390023007436/ownership.xml","form_type":"5"}},{"id":2036698,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T22:00:31.000Z","date":"2021-12-03","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-23-007436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390023007436/ownership.xml","form_type":"5"}},{"id":2063333,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T13:55:09.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":84745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 3, 2023, the Reporting Person was granted 84,745 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":85134,"source":{"system":"sec-edgar","filing":"0001104659-23-001225","document":"tm231522-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465923001225/tm231522-2_4seq1.xml","form_type":"4"}},{"id":2080091,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-20T22:30:46.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":57042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":57042,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":57042},"source":{"system":"sec-edgar","filing":"0001213900-22-081473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022081473/ownership.xml","form_type":"4"}},{"id":2145331,"issuer":{"id":93047,"kind":"organization","name":"PaxMedica, Inc.","symbol":"PXMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T21:26:08.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":51583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 51,583 restricted stock units (\"RSUs\"). The RSUs are subject to time-based vesting with one-third of the RSUs vesting on the one-year anniversary of the reporting person's service on the Board of Directors of PaxMedica, Inc. (the \"Company\"), followed by 8.3325% of the remaining RSUs vesting on a quarterly basis thereafter, subject to the reporting person's continuous service to the Company as of such vesting dates."}],"balance_after":51583,"source":{"system":"sec-edgar","filing":"0001104659-22-105940","document":"tm2227474d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000110465922105940/tm2227474d2_4.xml","form_type":"4"}},{"id":2255537,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T22:38:43.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":91235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 17, 2021, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan (the \"Plan\") increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2022, at the 2022 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments, at 6.25% per quarter, commencing on March 17, 2022."}],"balance_after":150000,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":91235},"source":{"system":"sec-edgar","filing":"0001213900-22-029832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022029832/ownership.xml","form_type":"4"}},{"id":2305310,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":19800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.."}],"balance_after":77511,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":19800},"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2305309,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":3300,"price":29,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2305308,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":3300,"price":29,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":3300,"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2305307,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":3300,"price":29,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":6600,"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2305306,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":3300,"price":29,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":9900,"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2305305,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":3300,"price":29,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":13200,"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2305304,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":3300,"price":29,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2305303,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:00:12.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":19800,"price":3.24,"value":64152.0,"ownership":{"direct":true},"balance_after":19800,"source":{"system":"sec-edgar","filing":"0001213900-22-018207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390022018207/ownership.xml","form_type":"4"}},{"id":2369507,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-28T21:31:41.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 7, 2023."}],"balance_after":109555,"derivative":{"exercise_price":3.78,"expiration_date":"2032-02-07","underlying":"Common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-005612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000149315222005612/ownership.xml","form_type":"4"}},{"id":2454711,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2022-01-04T02:07:34.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":34482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal quarterly installments on each of March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":34482,"derivative":{"exercise_price":1.45,"expiration_date":"2032-01-03","underlying":"Common stock, par value $0.0001 per share","underlying_shares":34482},"source":{"system":"sec-edgar","filing":"0001140361-22-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000114036122000305/form4.xml","form_type":"4"}},{"id":2462896,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-22T02:30:23.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":58765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 17, 2022."}],"balance_after":58765,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":58765},"source":{"system":"sec-edgar","filing":"0001213900-21-066819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021066819/ownership.xml","form_type":"4"}},{"id":2560143,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-09-24T21:00:49.000Z","date":"2021-09-22","kind":"exercise","acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.."}],"balance_after":97311,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001213900-21-049820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021049820/ownership.xml","form_type":"4"}},{"id":2560142,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-24T21:00:49.000Z","date":"2021-09-22","kind":"sale","acquired":false,"shares":1400,"price":29,"value":40600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-21-049820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021049820/ownership.xml","form_type":"4"}},{"id":2560141,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-24T21:00:49.000Z","date":"2021-09-22","kind":"sale","acquired":false,"shares":3300,"price":29,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":11400,"source":{"system":"sec-edgar","filing":"0001213900-21-049820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021049820/ownership.xml","form_type":"4"}},{"id":2560140,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-24T21:00:49.000Z","date":"2021-09-22","kind":"sale","acquired":false,"shares":1900,"price":29,"value":55100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."}],"balance_after":14700,"source":{"system":"sec-edgar","filing":"0001213900-21-049820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021049820/ownership.xml","form_type":"4"}},{"id":2560139,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-24T21:00:49.000Z","date":"2021-09-22","kind":"exercise","acquired":true,"shares":10000,"price":4.6,"value":46000.0,"ownership":{"direct":true},"balance_after":16600,"source":{"system":"sec-edgar","filing":"0001213900-21-049820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021049820/ownership.xml","form_type":"4"}},{"id":2596432,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-08-19T21:00:19.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":102500,"derivative":{"exercise_price":4.6,"exercise_date":"2018-12-20","expiration_date":"2028-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-21-043907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021043907/ownership.xml","form_type":"4"}},{"id":2596431,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T21:00:19.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":10000,"price":4.6,"value":46000.0,"ownership":{"direct":true},"balance_after":14700,"source":{"system":"sec-edgar","filing":"0001213900-21-043907","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021043907/ownership.xml","form_type":"4"}},{"id":2632315,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-16T21:00:23.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":1164,"price":32.4883,"value":37816.3812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $32.32 to $32.93 per share, inclusive"}],"balance_after":4700,"source":{"system":"sec-edgar","filing":"0001213900-21-037273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021037273/ownership.xml","form_type":"4"}},{"id":2632314,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-16T21:00:23.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":2136,"price":31.0262,"value":66271.9632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $30.66 to $31.60 per share, inclusive."}],"balance_after":5854,"source":{"system":"sec-edgar","filing":"0001213900-21-037273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021037273/ownership.xml","form_type":"4"}},{"id":2687208,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-02T21:00:59.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2480,"price":33.1854,"value":82299.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $32.85 to $33.42 per share, inclusive."}],"balance_after":6950,"source":{"system":"sec-edgar","filing":"0001213900-21-030571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021030571/ownership.xml","form_type":"4"}},{"id":2687207,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-02T21:00:59.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":520,"price":34.0779,"value":17720.508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $33.84 to $34.54 per share, inclusive."}],"balance_after":9430,"source":{"system":"sec-edgar","filing":"0001213900-21-030571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021030571/ownership.xml","form_type":"4"}},{"id":2727795,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T21:00:31.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":3000,"price":38.2157,"value":114647.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $37.94 to $38.94 per share, inclusive."}],"balance_after":9950,"source":{"system":"sec-edgar","filing":"0001213900-21-024716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021024716/ownership.xml","form_type":"4"}},{"id":2727794,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-05-05T20:16:05.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":19655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on May 3, 2022."}],"balance_after":59555,"derivative":{"exercise_price":8.61,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":19655},"source":{"system":"sec-edgar","filing":"0001493152-21-010526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000149315221010526/ownership.xml","form_type":"4"}},{"id":2758555,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T20:08:46.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":1691,"price":35.0403,"value":59253.1473,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $34.69 to $35.49 per share, inclusive."}],"balance_after":12950,"source":{"system":"sec-edgar","filing":"0001213900-21-020123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021020123/ownership.xml","form_type":"4"}},{"id":2758554,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T20:08:46.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":1309,"price":35.9265,"value":47027.7885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $35.80 to $36.12 per share, inclusive."}],"balance_after":14641,"source":{"system":"sec-edgar","filing":"0001213900-21-020123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021020123/ownership.xml","form_type":"4"}},{"id":2821395,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T21:08:00.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3000,"price":33.8726,"value":101617.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $33.56 to $34.28 per share, inclusive."}],"balance_after":15950,"source":{"system":"sec-edgar","filing":"0001213900-21-012891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021012891/ownership.xml","form_type":"4"}},{"id":2859886,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-16T13:59:26.000Z","date":"2020-03-19","kind":"gift","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68420,"source":{"system":"sec-edgar","filing":"0001493152-21-003826","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000149315221003826/ownership.xml","form_type":"5"}},{"id":2886294,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T22:05:40.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":1663,"price":33.9,"value":56375.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Sales prices range from $33.70 to $34.00 per share, inclusive."}],"balance_after":18950,"source":{"system":"sec-edgar","filing":"0001213900-21-006210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021006210/ownership.xml","form_type":"4"}},{"id":2886293,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T22:05:40.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":1337,"price":33.3,"value":44522.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Sales prices range from $32.68 to $33.59 per share, inclusive."}],"balance_after":20613,"source":{"system":"sec-edgar","filing":"0001213900-21-006210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021006210/ownership.xml","form_type":"4"}},{"id":2911162,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-11T21:12:12.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest from the date of grant in quarterly increments of 6.25%."}],"balance_after":100000,"derivative":{"exercise_price":33.43,"exercise_date":"2021-04-07","expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-21-001432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021001432/ownership.xml","form_type":"4"}},{"id":2916356,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2021-01-07T02:40:26.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":41237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in equal quarterly installments on each of March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021."}],"balance_after":41237,"derivative":{"exercise_price":0.97,"expiration_date":"2031-01-03","underlying":"Common stock, par value $0.0001 per share","underlying_shares":41237},"source":{"system":"sec-edgar","filing":"0001415889-21-000249","document":"form4-01062021_060119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588921000249/form4-01062021_060119.xml","form_type":"4"}},{"id":2921791,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:00:10.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":3000,"price":32.1139,"value":96341.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $32.01 to $32.38. The average weighted price was $32.1139. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21950,"source":{"system":"sec-edgar","filing":"0001213900-21-000426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390021000426/ownership.xml","form_type":"4"}},{"id":2961244,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T21:01:34.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":3000,"price":35.7397,"value":107219.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $34.54 to $36.065. The average weighted price was $35.7397. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":24950,"source":{"system":"sec-edgar","filing":"0001213900-20-040481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020040481/ownership.xml","form_type":"4"}},{"id":2961243,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T21:01:34.000Z","date":"2020-11-24","kind":"gift","acquired":false,"shares":21223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Gift to a family trust."}],"balance_after":27950,"source":{"system":"sec-edgar","filing":"0001213900-20-040481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020040481/ownership.xml","form_type":"4"}},{"id":2995134,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T21:03:15.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":3000,"price":30.2879,"value":90863.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $30.00 to $31.33. The average weighted price was $30.2879. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":49173,"source":{"system":"sec-edgar","filing":"0001213900-20-034800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020034800/ownership.xml","form_type":"4"}},{"id":3016749,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T20:02:46.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":3000,"price":37.9852,"value":113955.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $37.04 to $38.58. The average weighted price was $37.9852. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":52173,"source":{"system":"sec-edgar","filing":"0001213900-20-029901","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020029901/ownership.xml","form_type":"4"}},{"id":3041472,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-02T20:36:41.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":3000,"price":34.7356,"value":104206.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $34.22 to $35.60. The average weighted price was $34.7356. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":55173,"source":{"system":"sec-edgar","filing":"0001213900-20-025044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020025044/ownership.xml","form_type":"4"}},{"id":3052655,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2020-08-19T20:13:23.000Z","date":"2020-08-18","kind":"exercise","acquired":false,"shares":26362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":33404,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":26362},"source":{"system":"sec-edgar","filing":"0001213900-20-022881","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020022881/ownership.xml","form_type":"4"}},{"id":3052654,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:13:23.000Z","date":"2020-08-18","kind":"tax_withholding","acquired":false,"shares":2189,"price":39.03,"value":85436.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects 2,189 shares withheld at the market price of $39.03 per share to fund the cashless exercise of 26,362 options owned by Mr. Casamento, which cashless exercise was approved in advance by the Board of Directors."}],"balance_after":58173,"source":{"system":"sec-edgar","filing":"0001213900-20-022881","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020022881/ownership.xml","form_type":"4"}},{"id":3052653,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:13:23.000Z","date":"2020-08-18","kind":"exercise","acquired":true,"shares":26362,"price":3.24,"value":85412.88,"ownership":{"direct":true},"balance_after":60362,"source":{"system":"sec-edgar","filing":"0001213900-20-022881","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020022881/ownership.xml","form_type":"4"}},{"id":3069980,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-04T19:30:48.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":3000,"price":35.7378,"value":107213.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $35.40 to $36.69. The average weighted price was $35.7378. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001213900-20-020143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020020143/ownership.xml","form_type":"4"}},{"id":3092625,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T17:26:14.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":3000,"price":43.8924,"value":131677.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $43.03 to $44.63. The average weighted price was $43.8924. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37000,"source":{"system":"sec-edgar","filing":"0001213900-20-016524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020016524/ownership.xml","form_type":"4"}},{"id":3180863,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2020-04-07T23:53:35.000Z","date":"2020-04-06","kind":"grant","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options issued in connection with the Reporting Person's service on the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options vest immediately, with the remainder vesting in equal installments on each of June 30, 2020, September 30, 2020 and December 31, 2020."}],"balance_after":80000,"derivative":{"exercise_price":0.97,"expiration_date":"2030-04-06","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-20-000967","document":"form4-04072020_040421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588920000967/form4-04072020_040421.xml","form_type":"4"}},{"id":3198238,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-24T00:15:17.000Z","date":"2020-03-19","kind":"gift","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"La Jolla Lenox Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 11, 2020, the Reporting Person transferred 9,000 shares of the Issuer's common stock to a family trust of which the Trustee is someone other than the Reporting Person.  The Reporting Person and members of his immediate family are the sole beneficiaries of the trust."}],"balance_after":116998,"source":{"system":"sec-edgar","filing":"0001415889-20-000846","document":"form4-03232020_050303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588920000846/form4-03232020_050303.xml","form_type":"4"}},{"id":3198237,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-24T00:15:17.000Z","date":"2020-03-19","kind":"gift","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 11, 2020, the Reporting Person transferred 9,000 shares of the Issuer's common stock to a family trust of which the Trustee is someone other than the Reporting Person.  The Reporting Person and members of his immediate family are the sole beneficiaries of the trust."}],"balance_after":107998,"source":{"system":"sec-edgar","filing":"0001415889-20-000846","document":"form4-03232020_050303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588920000846/form4-03232020_050303.xml","form_type":"4"}},{"id":3203023,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:30:37.000Z","date":"2020-03-17","kind":"gift","acquired":true,"shares":21484,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares of common stock held by a family trust. Mr. Casamento disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Mr. Casamento is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":21484,"source":{"system":"sec-edgar","filing":"0001213900-20-006781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020006781/ownership.xml","form_type":"4"}},{"id":3203022,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:30:37.000Z","date":"2020-03-17","kind":"gift","acquired":false,"shares":21484,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001213900-20-006781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390020006781/ownership.xml","form_type":"4"}},{"id":3209271,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-16T20:56:15.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":27400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021."}],"balance_after":27400,"derivative":{"exercise_price":3.58,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":27400},"source":{"system":"sec-edgar","filing":"0001493152-20-004058","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000149315220004058/ownership.xml","form_type":"4"}},{"id":3211464,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T20:10:24.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":8414,"price":1.04,"value":8750.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Based on the stock price at December 31, 2019 at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors."}],"balance_after":116998,"source":{"system":"sec-edgar","filing":"0001415889-20-000739","document":"form4-03132020_040311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588920000739/form4-03132020_040311.xml","form_type":"4"}},{"id":3211463,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T20:10:24.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":14584,"price":0.6,"value":8750.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Based on the stock price at September 30, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors."}],"balance_after":108584,"source":{"system":"sec-edgar","filing":"0001415889-20-000739","document":"form4-03132020_040311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588920000739/form4-03132020_040311.xml","form_type":"4"}},{"id":3323819,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T21:11:42.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":7500,"price":1.04,"value":7800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2019."}],"balance_after":94000,"source":{"system":"sec-edgar","filing":"0001415889-20-000046","document":"form4-01032020_010128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588920000046/form4-01032020_010128.xml","form_type":"4"}},{"id":3330550,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-12-27T22:10:42.000Z","date":"2019-12-24","kind":"exercise","acquired":false,"shares":21094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":91406,"derivative":{"exercise_price":4.6,"exercise_date":"2018-12-20","expiration_date":"2019-12-26","underlying":"Common Stock","underlying_shares":2388},"source":{"system":"sec-edgar","filing":"0001213900-19-027115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019027115/ownership.xml","form_type":"4"}},{"id":3330549,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-12-27T22:10:42.000Z","date":"2019-12-24","kind":"exercise","acquired":false,"shares":46484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":59766,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2019-12-26","underlying":"Common Stock","underlying_shares":3706},"source":{"system":"sec-edgar","filing":"0001213900-19-027115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019027115/ownership.xml","form_type":"4"}},{"id":3330548,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-27T22:10:42.000Z","date":"2019-12-24","kind":"tax_withholding","acquired":false,"shares":2388,"price":40.64,"value":97048.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects 2,388 shares withheld at the market price of $40.64 per share to fund the cashless exercise of 21,094 options owned by Mr. Casamento, which cashless exercise was approved by the Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares of common stock held by Mr. Casamento remain subject to the terms of the Lock-Up Agreement, dated November 21, 2019, between Mr. Casamento and Jefferies LLC, as representative of the several underwriters listed on Schedule A to the Underwriting Agreement, dated December 3, 2019, by and among Jefferies LLC, SVB Leerink LLC and Relmada Therapeutics, Inc."}],"balance_after":61484,"source":{"system":"sec-edgar","filing":"0001213900-19-027115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019027115/ownership.xml","form_type":"4"}},{"id":3330547,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-27T22:10:42.000Z","date":"2019-12-24","kind":"tax_withholding","acquired":false,"shares":3706,"price":40.64,"value":150611.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 3,706 shares withheld at the market price of $40.64 per share to fund the cashless exercise of 46,484 options owned by Mr. Casamento, which cashless exercise was approved by the Board of Directors."}],"balance_after":63872,"source":{"system":"sec-edgar","filing":"0001213900-19-027115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019027115/ownership.xml","form_type":"4"}},{"id":3330546,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-27T22:10:42.000Z","date":"2019-12-24","kind":"exercise","acquired":true,"shares":21094,"price":4.6,"value":97032.4,"ownership":{"direct":true},"balance_after":67578,"source":{"system":"sec-edgar","filing":"0001213900-19-027115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019027115/ownership.xml","form_type":"4"}},{"id":3330545,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-27T22:10:42.000Z","date":"2019-12-24","kind":"exercise","acquired":true,"shares":46484,"price":3.24,"value":150608.16,"ownership":{"direct":true},"balance_after":46484,"source":{"system":"sec-edgar","filing":"0001213900-19-027115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019027115/ownership.xml","form_type":"4"}},{"id":3332723,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-12-23T21:54:46.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":100000,"price":43.47,"value":4347000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":43.47,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-19-026852","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019026852/ownership.xml","form_type":"4"}},{"id":3403355,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common","published_at":"2019-10-01T18:27:26.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":7500,"price":0.6,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2019."}],"balance_after":86500,"source":{"system":"sec-edgar","filing":"0001415889-19-001128","document":"form4-10012019_111009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588919001128/form4-10012019_111009.xml","form_type":"4"}},{"id":3441375,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-12T20:17:21.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":3500,"price":6.1057,"value":21369.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of purchase prices paid is $6.10 to $6.11. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":71920,"source":{"system":"sec-edgar","filing":"0001209191-19-045498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000120919119045498/doc4.xml","form_type":"4"}},{"id":3453401,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-07-30T21:05:35.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":500000,"price":2.2,"value":1100000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":500000,"derivative":{"exercise_price":2.2,"expiration_date":"2029-07-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-19-014039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390019014039/ownership.xml","form_type":"4"}},{"id":3471784,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common","published_at":"2019-07-02T22:41:15.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":7500,"price":1.7,"value":12750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2019."}],"balance_after":79000,"source":{"system":"sec-edgar","filing":"0001415889-19-000816","document":"form4-07022019_030701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588919000816/form4-07022019_030701.xml","form_type":"4"}},{"id":3481595,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-06-22T00:10:11.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest in quarterly installments over a one-year period beginning on June 30, 2019."}],"balance_after":30000,"derivative":{"exercise_price":1.75,"expiration_date":"2024-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-19-000788","document":"form4a-06212019_050657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588919000788/form4a-06212019_050657.xml","form_type":"4/A","original_submission_date":"2019-06-17"}},{"id":3488293,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-18T01:50:42.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors."}],"balance_after":101500,"source":{"system":"sec-edgar","filing":"0001415889-19-000744","document":"form4-06172019_060631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588919000744/form4-06172019_060631.xml","form_type":"4"}},{"id":3546730,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-30T00:24:36.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":7500,"price":2.42,"value":18150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2019."}],"balance_after":71500,"source":{"system":"sec-edgar","filing":"0001415889-19-000487","document":"form4-04292019_050423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588919000487/form4-04292019_050423.xml","form_type":"4"}},{"id":3604520,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-03-08T21:33:20.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020."}],"balance_after":12500,"derivative":{"exercise_price":7.31,"expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-018114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000120919119018114/doc4.xml","form_type":"4"}},{"id":3714371,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T22:58:32.000Z","date":"2018-12-28","kind":"grant","acquired":true,"shares":7500,"price":1.29,"value":9675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018."}],"balance_after":64000,"source":{"system":"sec-edgar","filing":"0001415889-19-000010","document":"form4-01022019_020116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588919000010/form4-01022019_020116.xml","form_type":"4"}},{"id":3714370,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T22:58:32.000Z","date":"2018-12-28","kind":"purchase","acquired":true,"shares":9000,"price":1.41,"value":12690.0,"ownership":{"direct":true},"balance_after":56500,"source":{"system":"sec-edgar","filing":"0001415889-19-000010","document":"form4-01022019_020116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000141588919000010/form4-01022019_020116.xml","form_type":"4"}},{"id":3723553,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-12-20T21:53:50.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":450000,"price":1.15,"value":517500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":450000,"derivative":{"exercise_price":1.15,"expiration_date":"2028-12-20","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001213900-18-017633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000121390018017633/ownership.xml","form_type":"4"}},{"id":3763418,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26788,"kind":"person","name":"CASAMENTO CHARLES J","position":1,"cik":"0001117167","reported_name":"CASAMENTO CHARLES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-11-16T00:24:59.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock.  The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock.  The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock.  The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8675},"source":{"system":"sec-edgar","filing":"0001209191-18-058827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117167/000120919118058827/doc4.xml","form_type":"4"}}],"next_cursor":"2018-11-16T00:24:59.000000Z,3763418"}